Jeffrey s Carlin MD
Lupus & Related, Rheumatoid Arthritis & Related, Scleroderma & Related, Vasculitis
Clinical Associate Professor, Rheumatology Inpatient Consult Service University of Washington
Join to View Full Profile
1959 NE Pacific St Suite BB561Seattle, WA 98195
Phone+1 206-992-0585
Dr. Carlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Carlin is a Rheumatologist based in Seattle, WA, with subspecialties in lupus, rheumatoid arthritis, scleroderma, and vasculitis. He graduated from New York University School of Medicine in 1975, completed his residency in Internal Medicine at the Medical College of Wisconsin Affiliated Hospitals, and finished a Rheumatology fellowship at the University of Washington. He has been a Clinical Associate Professor at UW Medicine/University of Washington Medical Center since 1980 and currently serves as a Research Associate at Virginia Mason Medical Center. Dr. Carlin has published several research articles, notably in the fields of autoimmune and inflammatory diseases, and participated in clinical trials for treatments related to systemic sclerosis. His recognitions include being named a Regional Top Doctor by Castle Connolly and receiving multiple CMS Meaningful Use Stage 1 Certifications.
Education & Training
University of WashingtonFellowship, Rheumatology, 1978 - 1980
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1975 - 1978
New York University School of MedicineClass of 1975
Certifications & Licensure
HI State Medical License 2023 - 2028
WA State Medical License 1978 - 2028
WI State Medical License 1976 - 1978
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2019
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2012, 2014, 2016-2017
Clinical Trials
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2019 Jun 26
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) Start of enrollment: 2019 Oct 14
Publications & Presentations
PubMed
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts.Hannah A DeBerg, Mitch L Fahning, Suraj R Varkhande, James D Schlenker, William P Schmitt
The Journal of Investigative Dermatology. 2025-11-01 - 2 citationsAntigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.Cliff Rims, Hannes Uchtenhagen, Kadin Brooks, Bernard Ng, Sylvia E Posso
Clinical and Experimental Immunology. 2025-01-21 - 1 citationsT cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.Hannah A DeBerg, Mitch L Fahning, Suraj R Varkhande, James D Schlenker, William P Schmitt
Biorxiv. 2024-12-22
Journal Articles
- Citrullinated Aggrecan Epitopes as Targets of Auto‐Reactive CD4+ T Cells in Patients with Rheumatoid ArthritisJeffrey Carlin, Jane H Buckner, Eddie A James, Mariana J Kaplan, Arthritis & Rheumatology
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
